BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2015
View Archived Issues
Autologous human bone marrow-derived mononuclear stem cells used for diabetic critical limb ischemia
Read More
MedImmune characterizes dual GLP-1/glucagon agonist for obesity
Read More
Galderma discloses new preclinical models for neurogenic skin disorders
Read More
Evofem seeks U.S. approval of Amphora as contraceptive
Read More
Innate Pharma receives initial payment from AstraZeneca under IPH-2201 agreement
Read More
First-in-human study testing Oncoceutics' ONC-201
Read More
Progenics Pharmaceuticals to conduct phase III trial of 1404
Read More
Allergan enters into licensing agreement with Merck & Co. for CGRP migraine program
Read More
Dyax's DX-2930 receives FDA breakthrough therapy designation
Read More
FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization
Read More
Prima Biomed receives positive scientific advice from the EMA for IMP-321
Read More
Trophogen awarded second year of phase II SBIR grant
Read More
Roche divulges BACE1 inhibitors
Read More
Esteve reports sigma1 and mu-opioid receptor ligands
Read More
Sanofi patents AMPK activators
Read More
GlaxoSmithKline discloses KMO inhibitors
Read More
AbbVie develops BRD4 inhibitors
Read More
Incyte and Vanderbilt University Medical Center form oncology research collaboration
Read More
Allergan to acquire ocular device developer Oculeve
Read More
Cortactin identified as biomarker, possible therapeutic target in CLL
Read More
DSMB recommends continuation of Genticel's phase II trial of ProCervix
Read More
Hetlioz approved in the E.U. for non-24-hour sleep-wake disorder in totally blind adults
Read More
GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis
Read More